Kathrin Strasser‐Weippl

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

Paul E. Goss, James N. Ingle, Kathleen I. Pritchard et al. · New England Journal of Medicine · 2016 · 648 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Challenges to effective cancer control in China, India, and Russia

Paul E. Goss, Kathrin Strasser‐Weippl, Brittany Bychkovsky et al. · The Lancet Oncology · 2014 · 504 citations

Public Health, Health Policy, Oncology +12

Planning cancer control in Latin America and the Caribbean

Paul E. Goss, Brittany Lee, Tanja Badovinac-Črnjević et al. · The Lancet Oncology · 2013 · 504 citations · Full text

Public Health, Health Policy, Oncology +14

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer

Lilian U. Thompson, Jianmin Chen, Tong Li et al. · Clinical Cancer Research · 2005 · 258 citations · Full text

Medicine, Nutritional Sciences, Oncology +13